HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

In-Gu Do Selected Research

Omeprazole (Prilosec)

10/2015Proton pump inhibitors enhance the effects of cytotoxic agents in chemoresistant epithelial ovarian carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


In-Gu Do Research Topics

Disease

51Neoplasms (Cancer)
01/2021 - 02/2009
11Stomach Neoplasms (Stomach Cancer)
11/2017 - 01/2013
9Neoplasm Metastasis (Metastasis)
10/2019 - 08/2010
8Breast Neoplasms (Breast Cancer)
10/2019 - 05/2013
8Carcinoma (Carcinomatosis)
11/2016 - 08/2010
7Colorectal Neoplasms (Colorectal Cancer)
10/2023 - 05/2013
7Carcinogenesis
12/2021 - 01/2012
5Uterine Cervical Neoplasms (Cancer of the Cervix)
12/2016 - 01/2012
5Hepatocellular Carcinoma (Hepatoma)
07/2012 - 02/2009
4Ovarian Neoplasms (Ovarian Cancer)
10/2015 - 08/2011
4Ovarian Epithelial Carcinoma
10/2015 - 08/2012
3Adenocarcinoma
10/2023 - 12/2014
3Lymphatic Metastasis
10/2017 - 01/2013
3Papillary Thyroid Cancer
10/2017 - 01/2015
3Glioblastoma (Glioblastoma Multiforme)
01/2017 - 05/2013
3Disease Progression
10/2015 - 12/2013
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2015 - 06/2012
2Inflammation (Inflammations)
12/2023 - 12/2021
2Rectal Neoplasms (Rectal Cancer)
10/2022 - 09/2016
2Nodular Goiter
10/2017 - 01/2015
2Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
03/2014 - 02/2011
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2012 - 08/2010
1Non-alcoholic Fatty Liver Disease
12/2023
1Fibrosis (Cirrhosis)
12/2023
1Alcoholic Fatty Liver
12/2023
1Type 2 Diabetes Mellitus (MODY)
12/2023
1Adenoma (Adenomas)
10/2023
1Appendicitis
11/2022
1Rare Diseases (Rare Disease)
11/2022
1Leukemia
11/2022
1Fever (Fevers)
11/2022
1Pain (Aches)
11/2022
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2022
1Squamous Intraepithelial Lesions
12/2021
1Spontaneous Remission
12/2021
1Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2021
1Colonic Neoplasms (Colon Cancer)
02/2018
1Thyroid Neoplasms (Thyroid Cancer)
10/2017
1Ductal Carcinoma
01/2017
1Oligodendroglioma
12/2015

Drug/Important Bio-Agent (IBA)

15Proteins (Proteins, Gene)FDA Link
02/2018 - 08/2010
13Biomarkers (Surrogate Marker)IBA
10/2022 - 01/2012
11ParaffinIBA
10/2022 - 08/2010
8Formaldehyde (Formol)FDA Link
10/2022 - 08/2010
8Messenger RNA (mRNA)IBA
10/2019 - 02/2009
6Small Interfering RNA (siRNA)IBA
10/2015 - 08/2010
3ProgranulinsIBA
01/2021 - 11/2016
3Lapatinib (GW572016)FDA Link
10/2019 - 04/2015
3Trastuzumab (Herceptin)FDA Link
10/2019 - 12/2014
3sphingosine kinaseIBA
10/2017 - 07/2015
3Dynamin IIIBA
12/2016 - 08/2010
3Irinotecan (Camptosar)FDA LinkGeneric
10/2015 - 06/2014
3Cetuximab (Erbitux)FDA Link
10/2015 - 06/2014
3Anaplastic Lymphoma KinaseIBA
09/2015 - 06/2012
3Phosphotransferases (Kinase)IBA
04/2015 - 05/2013
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2015 - 02/2011
2RNA (Ribonucleic Acid)IBA
10/2023 - 06/2012
2MethyltransferasesIBA
02/2018 - 05/2013
2SurvivinIBA
09/2016 - 03/2015
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
02/2016 - 05/2013
2Paclitaxel (Taxol)FDA LinkGeneric
10/2015 - 12/2014
2Monoclonal AntibodiesIBA
09/2015 - 12/2013
2tyrosine receptor (receptor, tyrosine)IBA
04/2015 - 05/2013
2Simvastatin (Zocor)FDA LinkGeneric
02/2015 - 06/2014
2Cadherins (E-Cadherin)IBA
12/2014 - 06/2010
2Complementary DNA (cDNA)IBA
03/2014 - 12/2013
2EnzymesIBA
12/2013 - 01/2013
2Matrix Metalloproteinase 9 (Gelatinase B)IBA
02/2013 - 06/2010
2Galectin 3 (LGALS3)IBA
02/2013 - 08/2011
2Laminin (Merosin)IBA
01/2013 - 08/2012
2Galectin 1 (LGALS1)IBA
01/2013 - 08/2012
2LectinsIBA
01/2013 - 08/2011
2PlatinumIBA
08/2011 - 12/2010
1LC15-0444IBA
12/2023
1LipidsIBA
12/2023
1Dipeptidyl-Peptidase IV InhibitorsIBA
12/2023
1InflammasomesIBA
12/2023
1Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA
12/2023
1AMP-Activated Protein KinasesIBA
12/2023
1Dual OxidasesIBA
10/2022
1C-Reactive ProteinIBA
12/2021
1Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)IBA
02/2018
1Arginine (L-Arginine)FDA Link
02/2018
1c-Mer Tyrosine KinaseIBA
11/2017
1SphingolipidsIBA
10/2017
1fascinIBA
01/2017
1N'- (3,4- dihydroxybenzylidene)- 3- hydroxy- 2- naphthahydrazideIBA
12/2016
1Cell Cycle ProteinsIBA
03/2016
1Estrogen Receptor alphaIBA
02/2016
1MMEIBA
01/2016
1LigandsIBA
12/2015
1CateninsIBA
12/2015
1Omeprazole (Prilosec)FDA LinkGeneric
10/2015

Therapy/Procedure

12Therapeutics
11/2022 - 05/2013
6Drug Therapy (Chemotherapy)
11/2022 - 12/2010
2Adjuvant Chemotherapy
04/2015 - 01/2014
2Ligation
03/2014 - 12/2013
1Consolidation Chemotherapy
11/2022
1Gastrectomy
11/2020
1Radiotherapy
09/2016